Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection.

Thorax · 2013 · PMC3756431 · PMID 23749840

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The MIC 50 for P aeruginosa isolates was increased in later cycles, but did not demonstrate a clear trend over the entire open-label study, or within individual cycles (see online supplementary figure S3).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.